Md Wasi Ahmad

Prof. Dr. Md Wasi Ahmad

Dhofar University
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
WXWenlong Xu
Wenlong Xu
SKSung June Kim
Sung June Kim
JBJong Su Baeck
Jong Su Baeck
YCYongmin Chang
Yongmin Chang
Gang Ho LeeGang Ho Lee
Gang Ho Lee
Gadolinium (Gd) is a unique and powerful element in chemistry and biomedicine which can be applied simultaneously to magnetic resonance imaging (MRI), X-ray computed tomography (CT) and neutron capture therapy for cancers. This multifunctionality can be maximized using gadolinium oxide (Gd2O3) nanoparticles (GNPs) because of the large amount of Gd per GNP, making both diagnosis and therapy (i.e., theragnosis) for cancers possible using only GNPs. In this study, the T1 MRI and CT dual imaging capability of GNPs is explored by synthesizing various iodine compound (IC) coated GNPs (IC-GNPs). All the IC-GNP samples showed stronger X-ray absorption and larger longitudinal water proton relaxivities (r1 = 26–38 s−1mM−1 and r2/r1 = 1.4–1.9) than the respective commercial contrast agents. In vivo T1 MR and CT images of mice were also acquired, supporting that the GNP is a potential dual imaging agent.

20 September 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
AFAtiya Fatima
Atiya Fatima
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
Abdullah Khamis Al SaidiAbdullah Khamis Al Saidi
Abdullah Khamis Al Saidi
ACArup Choudhury
Arup Choudhury
YCYongmin Chang
Yongmin Chang
Gang Ho LeeGang Ho Lee
Gang Ho Lee
Gadolinium (Gd) based contrast agents (CAs) (Gd-CAs) represent one of the most advanced developments in the application of Gd for magnetic resonance imaging (MRI). Current challenges with existing CAs generated an urgent requirement to develop multimodal CAs with good biocompatibility, low toxicity, and prolonged circulation time. This review discussed the Gd-CAs used in bioimaging applications, addressing their advantages and limitations. Future research is required to establish the safety, efficacy and theragnostic capabilities of Gd-CAs. Nevertheless, these Gd-CAs offer extraordinary potential as imaging CAs and promise to benefit bioimaging applications significantly.

17 August 2015 in Nanotechnology
Verified
Journal Article
Closed access
TTTirusew Tegafaw
Tirusew Tegafaw
WXWenlong Xu
Wenlong Xu
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
JBJong Su Baeck
Jong Su Baeck
YCYongmin Chang
Yongmin Chang
GLGang Ho Lee
Gang Ho Lee
A new type of dual-mode T 1 and T 2 magnetic resonance imaging (MRI) contrast agent based on mixed lanthanide oxide nanoparticles was synthesized. Gd 3+ ( 8 S 7/2 ) plays an important role in T 1 MRI contrast agents because of its large electron spin magnetic moment resulting from its seven unpaired 4f-electrons, and Dy 3+ ( 6 H 15/2 ) has the potential to be used in T 2 MRI contrast agents because of its very large total electron magnetic moment: among lanthanide oxide nanoparticles, Dy 2 O 3 nanoparticles have the largest magnetic moments at room temperature. Using these properties of Gd 3+ and Dy 3+ and their oxide nanoparticles, ultrasmall mixed gadolinium-dysprosium oxide (GDO) nanoparticles were synthesized and their potential to act as a dual-mode T 1 and T 2 MRI contrast agent was investigated in vitro and in vivo . The D-glucuronic acid coated GDO nanoparticles ( d avg = 1.0 nm) showed large r 1 and r 2 values ( r 2 / r 1 ≈ 6.6) and as a result clear dose-dependent contrast enhancements in R 1 and R 2 map images. Finally, the dual-mode imaging capability of the nanoparticles was confirmed by obtaining in vivo T 1 and T 2 MR images.

23 May 2023 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
BDBaban Dey
Baban Dey
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
BKBo Hye Kim
Bo Hye Kim
TKTahseen Kamal
Tahseen Kamal
DYDuck-Joo Yang
Duck-Joo Yang
ACArup Choudhury
Arup Choudhury

25 October 2021 in ACS Applied Energy Materials
Verified
Journal Article
Closed access
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
SASurbhi Anand
Surbhi Anand
BDBaban Dey
Baban Dey
AFAtiya Fatima
Atiya Fatima
DYDuck Joo Yang
Duck Joo Yang
ACArup Choudhury
Arup Choudhury

11 September 2012 in RSC Advances
Verified
Journal Article
Closed access
PDF file
WXWenlong Xu
Wenlong Xu
JPJa Young Park
Ja Young Park
KKKrishna Kattel
Krishna Kattel
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
BBBadrul Alam Bony
Badrul Alam Bony
Gang Ho LeeGang Ho Lee
Gang Ho Lee
We report the synthesis, characterization and application of highly water-soluble fluorescein-polyethyleneimine (PEI) coated gadolinium oxide (Gd2O3) nanoparticles to magnetic resonance imaging (MRI) and cell labeling (CL). The average particle diameter and average hydrodynamic diameter were estimated to be 3.92 and 7.5 nm, respectively. Fluorescein-PEI was prepared from EDC/NHS coupling method. The surface coating was characterized by the FT-IR absorption spectrum and the surface coating amount was estimated to be 22.42 wt% from a TGA analysis, corresponding to 0.65 nm−2 grafting density. The fluorescein-PEI coated gadolinium oxide nanoparticles showed r1 and r2 of 6.76 and 20.27 s−1mM−1, respectively, and a strong fluorescence at ∼527 nm. A pronounced positive contrast enhancement was clearly observed in 3 tesla T1 MR images of a rat with a liver tumor after injection of an aqueous sample solution into a rat tail vein. After treatment of DU145 cells with a sample solution, a strong fluorescence in confocal images was also observed. These two results together confirm the excellent MRI-CL dual functionality of fluorescein-PEI coated gadolinium oxide nanoparticles.